Literature DB >> 22075603

Should we switch to a 50-mg boosting dose of ritonavir for selected protease inhibitors?

Andrew Hill, Saye Khoo, Marta Boffito, David Back.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22075603     DOI： 10.1097/QAI.0b013e318237ccae

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  1 in total

1.  Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies.

Authors:  Alessandro Schipani; Laura Dickinson; Marta Boffito; Rupert Austin; Andrew Owen; David Back; Saye Khoo; Gerry Davies
Journal:  J Acquir Immune Defic Syndr       Date:  2013-01-01       Impact factor: 3.731
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.